GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (NYSE:SYK) » Definitions » Cyclically Adjusted FCF per Share

Stryker (Stryker) Cyclically Adjusted FCF per Share : $5.75 (As of Dec. 2023)


View and export this data going back to 1988. Start your Free Trial

What is Stryker Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Stryker's adjusted free cash flow per share for the three months ended in Dec. 2023 was $3.604. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $5.75 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Stryker's average Cyclically Adjusted FCF Growth Rate was 7.90% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 10.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 9.20% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 7.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Stryker was 81.70% per year. The lowest was 3.90% per year. And the median was 14.55% per year.

As of today (2024-04-28), Stryker's current stock price is $335.61. Stryker's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $5.75. Stryker's Cyclically Adjusted Price-to-FCF of today is 58.37.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Stryker was 62.24. The lowest was 24.89. And the median was 44.78.


Stryker Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Stryker's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker Cyclically Adjusted FCF per Share Chart

Stryker Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.93 4.31 4.96 5.33 5.75

Stryker Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.33 5.44 5.53 5.62 5.75

Competitive Comparison of Stryker's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Stryker's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stryker's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stryker's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Stryker's Cyclically Adjusted Price-to-FCF falls into.



Stryker Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Stryker's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=3.604/129.4194*129.4194
=3.604

Current CPI (Dec. 2023) = 129.4194.

Stryker Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 0.363 99.695 0.471
201406 0.815 100.560 1.049
201409 1.273 100.428 1.640
201412 1.613 99.070 2.107
201503 0.871 99.621 1.132
201506 0.758 100.684 0.974
201509 -1.539 100.392 -1.984
201512 1.782 99.792 2.311
201603 0.390 100.470 0.502
201606 1.001 101.688 1.274
201609 1.013 101.861 1.287
201612 1.358 101.863 1.725
201703 0.032 102.862 0.040
201706 1.367 103.349 1.712
201709 -0.166 104.136 -0.206
201712 1.294 104.011 1.610
201803 0.462 105.290 0.568
201806 1.294 106.317 1.575
201809 1.257 106.507 1.527
201812 2.347 105.998 2.866
201903 0.504 107.251 0.608
201906 0.920 108.070 1.102
201909 1.225 108.329 1.463
201912 1.410 108.420 1.683
202003 1.177 108.902 1.399
202006 1.361 108.767 1.619
202009 1.999 109.815 2.356
202012 2.812 109.897 3.312
202103 0.967 111.754 1.120
202106 2.019 114.631 2.279
202109 2.098 115.734 2.346
202112 2.077 117.630 2.285
202203 0.219 121.301 0.234
202206 1.010 125.017 1.046
202209 1.967 125.227 2.033
202212 2.132 125.222 2.203
202303 0.822 127.348 0.835
202306 1.396 128.729 1.403
202309 2.349 129.860 2.341
202312 3.604 129.419 3.604

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Stryker  (NYSE:SYK) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Stryker's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=335.61/5.75
=58.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Stryker was 62.24. The lowest was 24.89. And the median was 44.78.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Stryker Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Stryker's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Stryker (Stryker) Business Description

Address
2825 Airview Boulevard, Kalamazoo, MI, USA, 49002
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Executives
Srikant Datar director ICF INTERNATIONAL, INC., 9300 LEE HIGHWAY, FAIRFAX VA 22031
Berry William E Jr officer: Vice President, Controller 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Kevin Lobo officer: Group Pres., Neurotech & Spine STRYKER, 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Viju Menon officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Allan C. Golston director 2825 AIRVIEW BLVD., KALAMAZOO MI 49002
Ronda E Stryker director 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Robert S Fletcher officer: VP, Chief Legal Officer 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
James Andrew Pierce officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Glenn S Boehnlein officer: Vice President, CFO 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
M Kathryn Fink officer: VP, Global Human Resources 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Spencer S Stiles officer: Group President 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Giovanni Caforio director BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, LAWRENCEVILLE NJ 08543
Timothy J Scannell officer: Group President 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Roch Doliveux director 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Katherine Ann Owen officer: VP 2825 AIRVIEW BLVD., KALAMAZOO MI 49002

Stryker (Stryker) Headlines

From GuruFocus

Q2 2021 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2022 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q1 2021 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2020 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2023 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Stryker Corp Corporate Analyst Meeting Transcript

By GuruFocus Research 01-23-2024

Q3 2022 Stryker Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024